The Polish Ministry of Health are targeting new psychoactive substances due to an urgent need in restricting the production and circulation of the dangerous drugs and replacement substances. Whilst new psychoactive substances continue to emerge into the market, cannabis is the most commonly used illicit drug in Poland, followed by amphetamines and cocaine, according to the European Monitoring Centre for Drugs and Drug Addiction.
With significant reinvestment in research and development Randox Toxicology provide trusted solutions for screening drugs of abuse. Our level of expertise in toxicology allows us to adapt quickly to the ever changing market influences and develop assays for current and novel drug trends. As the primary manufacturer of Biochip Array Technology, our cutting-edge multiplex testing capabilities provide rapid and accurate drugs of abuse detection from a single sample.
The Evidence MultiSTAT is designed to work across a variety of matrices and generate results in under 20 minutes. Utilising our Biochip Array Technology, the fully automated analyser enables on-site simultaneous detection of up to 21 classical, prescription and synthetic drugs. These include a number of new psychoactive substances; α-PVP (Flakka), AB-PINACA, Buprenorphine, JWH-018 and UR-144/XLR-11.
To find out more information regarding the Evidence MultiSTAT and our extensive drugs of abuse test menu, visit us at the XXXV Conference of Scientific Toxicologists from the 9th – 11th May in Szczecin, Poland.